29
total announcements
TATVA.NS · 15 min delayed
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about a copy of newspaper publication regarding the notice of the 30th Annual General Meeting of the Company scheduled to be held on September 25, 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has announced the record date for the purpose of dividend as 11-Sep-2026. The company's share transfer books will be closed from 12-Sep-2026 to 25-Sep-2026 for the 30th Annual General Meeting.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, as per Regulation 34(2)(f) of the SEBI Listing Regulations.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the resignation of a Director/KMP/SMP, but no further details are provided.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding the resignation of a Senior Management Personnel, Mr. Ajay Rawat, Assistant Vice President – Research and Development, effective from 13 November 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Copy of Newspaper Publication regarding the 30th Annual General Meeting to be held on 25 September 2026 through Video Conferencing/OAVM.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding the final dividend for FY 2025-26, with a dividend of Rs. 2.00 per equity share, and the process for claiming tax exemption or withholding tax on dividend payable to shareholders.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of Analyst(s)/Financial Institution(s)/Investor(s) meeting on 12 August 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of Analyst(s)/Financial Institution(s)/Investor(s) meeting on 12 August 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an analyst/institutional investor meet/conference call on August 6, 2026, to be held virtually.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an Analyst(s)/Financial Institution(s)/Investor(s) meeting on August 6, 2026, to be held virtually. The meeting will discuss publicly available information, and no confidential or unpublished price-sensitive information will be shared.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about a scheduled analyst/institutional investor meet on July 31, 2026, with Motilal Oswal AMC, to be held virtually.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an analyst/institutional investor meet/conference call on July 30, 2026, with Ventura Securities Limited.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an Analysts/Institutional Investor Meet/Con. Call, which will be held on 30 July 2026, and will be participated by the Company. The meeting will be a one-to-one meeting with Tamohara Investment Managers Pvt. Ltd. through a virtual meeting.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an investor meeting with Alchemy Capital Management on 28 July 2026, which will be a virtual meeting.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the transcript of the earnings call held on 17 July 2026 post announcement of financial results for the quarter ended 30 June 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an analyst/institutional investor meet/conference call. The company will participate in a virtual meeting on July 27, 2026, hosted by ULJK Financial Services Pvt. Ltd. The meeting will refer to publicly available information and will not share any confidential or unpublished price-sensitive information.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has held a groundbreaking ceremony for its new greenfield unit at Dahej - III, Gujarat, India, as part of its growth strategy to meet growing market demands.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Copy of Newspaper Publication of extract of financial results of the Company for the quarter ended 30 June 2026.